Last reviewed · How we verify
AC-1202 mixed in water
At a glance
| Generic name | AC-1202 mixed in water |
|---|---|
| Sponsor | Cerecin |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides (PHASE1)
- Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production (PHASE1)
- Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AC-1202 mixed in water CI brief — competitive landscape report
- AC-1202 mixed in water updates RSS · CI watch RSS
- Cerecin portfolio CI